X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-scrap-two-trials-drug-that-curbs-potassium-2023-12-01/
https://www.astrazeneca.com/media-centre/press-releases/2020/lokelma-label-update-approved-in-china-for-patients-with-hyperka.html
http://www.pharmatimes.com/news/eu_approves_label_update_for_az_lokelma_1339580
https://www.astrazeneca.com/media-centre/medical-releases/lokelma-us-label-updated-to-include-dosing-guidance-for-the-treatment-of-hyperkalaemia-in-patients-with-end-stage-renal-disease-on-haemodialysis.html
https://www.biospectrumasia.com/news/34/15198/china-approves-astrazenecas-lokelma-to-treat-hyperkalaemia.html
http://www.pharmatimes.com/news/nice_turns_down_hyperkalaemia_therapies_1257420
http://www.pmlive.com/pharma_news/az_gets_us_approval_for_veltassa_rival_lokelma_1236112
https://www.businesswire.com/news/home/20180518005795/en/LOKELMATM-Approved-Treatment-Adults-Hyperkalemia
https://www.pharmacompass.com/pdf/news/astrazenecas-lokelma-sodium-zirconium-cyclosilicate-receives-approval-in-europe-1523363068.pdf
Market Place
Share 
